Bluebird Bio (BLUE)
4.26 x 5 4.50 x 1
Post-market by (Cboe BZX)
4.19 +0.03 (+0.72%) 04/28/25 [NASDAQ]
4.26 x 5 4.50 x 1
Post-market 4.19 unch (unch) 16:02 ET
for Mon, Apr 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -240,715 | -211,913 | -230,342 | -819,378 | -618,695 |
Depreciation Amortization | 61,244 | 28,525 | 8,344 | 19,649 | 19,356 |
Accounts payable and accrued liabilities | 16,504 | 2,841 | -7,709 | 9,286 | -20,100 |
Other Working Capital | -130,045 | -49,721 | -75,044 | -12,163 | -50,131 |
Other Operating Activity | 32,992 | -4,778 | -11,468 | 166,967 | 199,219 |
Operating Cash Flow | $-260,020 | $-235,046 | $-316,219 | $-635,639 | $-470,351 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 0 | 71,077 | 161,661 | 585,560 | -55,359 |
PPE Investments | -2,599 | -4,189 | -8,208 | -14,503 | -28,986 |
Purchase Sale Intangibles | 0 | -4,868 | -5,000 | -8,500 | N/A |
Other Investing Activity | 6,496 | 88,062 | 97,000 | -8,500 | 0 |
Investing Cash Flow | $3,897 | $154,950 | $250,453 | $562,557 | $-84,345 |
Cash Flows From Financing Activities | |||||
Debt Issued | 73,985 | 0 | N/A | N/A | N/A |
Debt Repayment | -85,950 | -54,367 | -36,734 | N/A | N/A |
Common Stock Issued | N/A | 248,198 | 54,237 | 80,330 | 546,715 |
Other Financing Activity | 99,434 | 2,417 | 16 | -174,284 | 0 |
Financing Cash Flow | $87,469 | $196,248 | $17,519 | $-93,954 | $546,715 |
Beginning Cash Position | 274,597 | 158,445 | 206,692 | 373,728 | 381,709 |
End Cash Position | 105,943 | 274,597 | 158,445 | 206,692 | 373,728 |
Net Cash Flow | $-168,654 | $116,152 | $-48,247 | $-167,036 | $-7,981 |
Free Cash Flow | |||||
Operating Cash Flow | -260,020 | -235,046 | -316,219 | -635,639 | -470,351 |
Capital Expenditure | -2,599 | -4,189 | -8,208 | -14,503 | -28,986 |
Free Cash Flow | -262,619 | -239,235 | -324,427 | -650,142 | -499,337 |